| Ticker Details |
Exact Sciences Corporation
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
|
| IPO Date: |
January 31, 2001 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$19.22B |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.76 | 2.70%
|
| Avg Daily Range (30 D): |
$1.31 | 1.91%
|
| Avg Daily Range (90 D): |
$0.99 | 1.75%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.25M |
| Avg Daily Volume (30 D): |
6.67M |
| Avg Daily Volume (90 D): |
3.96M |
| Trade Size |
| Avg Trade Size (Sh.): |
101 |
| Avg Trade Size (Sh.) (30 D): |
114 |
| Avg Trade Size (Sh.) (90 D): |
87 |
| Institutional Trades |
| Total Institutional Trades: |
20,831 |
| Avg Institutional Trade: |
$3.29M |
| Avg Institutional Trade (30 D): |
$5.63M |
| Avg Institutional Trade (90 D): |
$4.69M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
7 |
| Market Closing Trades |
| Avg Closing Trade: |
$10.49M |
| Avg Closing Trade (30 D): |
$25.28M |
| Avg Closing Trade (90 D): |
$19.45M |
| Avg Closing Volume: |
180.87K |
|
|
| News |
Feb 12, 2026 @ 10:00 PM
Mdxhealth to Present Fourth Quarter and Full Year ...
Source: Na
|
Jan 26, 2026 @ 11:20 AM
3 Reasons to Buy This Dividend King After Its Stee...
Source: Keith Speights
|
Jan 22, 2026 @ 2:48 PM
Abbott Labs Stock Hits 52-Week Low As Outlook Disa...
Source: Vandana Singh
|
Jan 21, 2026 @ 9:52 PM
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC ...
Source: Halper Sadeh Llc
|
Jan 17, 2026 @ 5:56 PM
Halper Sadeh LLC Encourages SEE, EXAS, ZEUS Shareh...
Source: Halper Sadeh Llc
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-1.1
|
$-.45
|
$-1.1
|
|
Diluted EPS
|
$-1.1
|
$-.45
|
$-1.1
|
|
Revenue
|
$3.25B
|
$878.38M
|
$3.25B
|
|
Gross Profit
|
$2.26B
|
$615.83M
|
$2.26B
|
|
Net Income / Loss
|
$-207.95M
|
$-85.96M
|
$-207.95M
|
|
Operating Income / Loss
|
$-206.3M
|
$-82.6M
|
$-206.3M
|
|
Cost of Revenue
|
$984.24M
|
$262.56M
|
$984.24M
|
|
Net Cash Flow
|
$349.36M
|
$166.96M
|
$349.36M
|
|
PE Ratio
|
|
|
|
|
|
|